Silo Pharma Announces Positive Results From Study For Depression Treatment, Remission, And Relapse Prevention
Silo Pharma Inc 
SILO:
SILO PHARMA ANNOUNCES POSITIVE RESULTS FROM STUDY FOR DEPRESSION TREATMENT, REMISSION, AND RELAPSE PREVENTION
SILO PHARMA INC - EXPECTS TO COMPLETE AND ENTER INTO EXCLUSIVE LICENSE AGREEMENT IN FIRST HALF OF 2024
SILO PHARMA - UNDER TERMS OF LICENSE AGREEMENT, TO BE GRANTED EXCLUSIVE LICENSE TO FURTHER DEVELOP, MANUFACTURE, AND COMMERCIALIZE SPC-15 WORLDWIDE